Bond Screener
Celgene
LEI 4SIHMF0MOSTTL8CD0X64, SWIFT CELGUSA1XXX
Organization name
Celgene Corporation
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
191 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
|
General information
-
Organization nameCelgene Corporation
-
Organization statusOperating organization
-
Address86 Morris Avenue Summit, USA, 07901
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameCelgene Corporation
-
Organization statusOperating organization
-
Address86 Morris Avenue Summit, USA, 07901
-
Site
-
IR Site
Codes
-
LEI4SIHMF0MOSTTL8CD0X64
-
SWIFTCELGUSA1XXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0000816284
